What will the $100 genome mean?

What will the $100 genome mean?

A company has slashed the cost of assessing a person's genome to just $100. With lower costs - and as other genetic tools mature and evolve - a wave of new therapies could be coming in the near future.

Adobe Stock

In May 2022, Californian biotech Ultima Genomics announced that its UG 100 platform was capable of sequencing an entire human genome for just $100, a landmark moment in the history of the field. The announcement was particularly remarkable because few had previously heard of the company, a relative unknown in an industry long dominated by global giant Illumina which controls about 80 percent of the world’s sequencing market.

Ultima’s secret was to completely revamp many technical aspects of the way Illumina have traditionally deciphered DNA. The process usually involves first splitting the double helix DNA structure into single strands, then breaking these strands into short fragments which are laid out on a glass surface called a flow cell. When this flow cell is loaded into the sequencing machine, color-coded tags are attached to each individual base letter. A laser scans the bases individually while a camera simultaneously records the color associated with them, a process which is repeated until every single fragment has been sequenced.

Instead, Ultima has found a series of shortcuts to slash the cost and boost efficiency. “Ultima Genomics has developed a fundamentally new sequencing architecture designed to scale beyond conventional approaches,” says Josh Lauer, Ultima’s chief commercial officer.

Keep Reading Keep Reading
David Cox
David Cox is a science and health writer based in the UK. He has a PhD in neuroscience from the University of Cambridge and has written for newspapers and broadcasters worldwide including BBC News, New York Times, and The Guardian. You can follow him on Twitter @DrDavidACox.
Scientists forecast new disease outbreaks

A mosquito under the microscope.

Joacim Rocklov

Two years, six million deaths and still counting, scientists are searching for answers to prevent another COVID-19-like tragedy from ever occurring again. And it’s a gargantuan task.

Our disturbed ecosystems are creating more favorable conditions for the spread of infectious disease. Global warming, deforestation, rising sea levels and flooding have contributed to a rise in mosquito-borne infections and longer tick seasons. Disease-carrying animals are in closer range to other species and humans as they migrate to escape the heat. Bats are thought to have carried the SARS-CoV-2 virus to Wuhan, either directly or through another host animal, but thousands of novel viruses are lurking within other wild creatures.

Understanding how climate change contributes to the spread of disease is critical in predicting and thwarting future calamities. But the problem is that predictive models aren’t yet where they need to be for forecasting with certainty beyond the next year, as we could for weather, for instance.

Keep Reading Keep Reading
Eve Glicksman
Eve Glicksman is a freelance writer and editor in Silver Spring, MD. She writes for multiple media outlets and associations on health care, trends, culture, psychology, lifestyle, and travel. To see her work in the Washington Post, WebMD, and U.S. News & World Report, visit eveglicksman.com.
Scientists use AI to predict how hospital stays will go

In this week's Friday Five, research on the best time to wrap up eating for the night, how to use AI to predict how hospital stays will go, a new way to armor the shields of our livers against cancer, super neurons in super agers - and much more.

Adobe Stock

The Friday Five covers five stories in research that you may have missed this week. There are plenty of controversies and troubling ethical issues in science – and we get into many of them in our online magazine – but this news roundup focuses on scientific creativity and progress to give you a therapeutic dose of inspiration headed into the weekend.

Keep Reading Keep Reading
Matt Fuchs
Matt Fuchs is the host of the Making Sense of Science podcast and served previously as the editor-in-chief of Leaps.org. He writes as a contributor to the Washington Post, and his articles have also appeared in the New York Times, WIRED, Nautilus Magazine, Fortune Magazine and TIME Magazine. Follow him @fuchswriter.